STREAMED LIVE AT 10:00 AM. CLICK HERE TO ACCESS (only with e-mail).

Registration closed. If you were unable to attend, you can view the recorded event:

CataloniaBio & HealthTech, Biocat and EY will present the Study on investment in the life sciences and healthcare industry in Catalonia 2020 on 2 July, online.

Thanks to all the hard work in recent years, this study has become the benchmark report on investment and the main growth indicators for the ecosystem.

10:00 am  Welcome

10:05 am  Investment in life sciences and healthcare in Catalonia: data, analysis and challenges 

• Judit Anido, president of CataloniaBio & HealthTech and general manager of Mosaic Biomedicals
• Jordi Naval, CEO of Biocat

10:20 am  International overview of the life sciences and healthcare industry

• Silvia Ondategui, managing partner of the EY Life Sciences division

10:30 am  Trends driven by Covid-19: investors opinion

• Montserrat Vendrell, managing partner of Alta Life Sciences and CataloniaBio & HealthTech board member
• Clara Campàs, partner of Asabys Partners
• Lluís Pareras, managing partner of Invivo Capital
• Guillem Laporta, principal of Ysios Capital

10:40 am  Trends driven by Covid-19: experts opinion

• Marc Martinell, co-founder and CEO of Minoryx Therapeutics
• Carolina Aguilar, co-founder and CEO of Inbrain Neuroelectronics
• Cristian Pascual, co-founder and CEO of Mediktor

10:45 am  Projected vision of KOL and investors in the healthcare and life sciences ecosystem in Catalonia by Jordi Naval

10:50 am  Question time

11:15 am  Closing

The event will be moderated by Melqui Calzado, general secretary of CataloniaBio & HealthTech.

After the event, the digital version of the study will be available in the “Publications” section. 

On Twitter with hashtag #InvestmentLifeSciences

Language: Catalan / Spanish

Registration fees: free of charge

This activity will be streamed live from the Sala Gaudí in EY in Barcelona. Access will be activated 5 minutes before the session (the link will be sent to the participants registered).

Qüestions: Melqui Calzado (general secretary) · secretaria@cataloniabioht.org

The Study on investment in the life sciences and healthcare industry in Catalonia

The Study on investment in the life sciences and healthcare industry in Catalonia published annually since 2017 compiles the main indicators and analyses global and local trends in attracting capital and the future outlook for companies. It is a valuable tool for decision-making regarding future challenges. By CataloniaBio & HealthTech and Biocat in collaboration with EY, a global benchmark, provides the methodology, rigour and reliability.

Related information:

• Download the study (pdf)
• News: Investment in start-ups in the field of life sciences and healthcare in Catalonia grew to €112M in 2019
• Press release